Turn TRAIL Into Better Anticancer Therapeutic Through TRAIL Fusion Proteins

ABSTRACT Background TNF‐related apoptosis‐inducing ligand (TRAIL) belongs to the tumor necrosis factor superfamily. TRAIL selectively induces apoptosis in tumor cells while sparing normal cells, which makes it an attractive candidate for cancer therapy. Recombinant soluble TRAIL and agonistic antibo...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Yan Wang, Xin Qian, Yubo Wang, Caiyuan Yu, Li Feng, Xiaoyan Zheng, Yaya Wang, Qiuhong Gong
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2025-01-01
Serija:	Cancer Medicine
Teme:	apoptosis cancer fusion protein resistance TRAIL
Online dostop:	https://doi.org/10.1002/cam4.70517
Oznake:	Označite Brez oznak, prvi označite!